Kmall is this odd?

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
rccola335
Posts: 317
Joined: Sat Sep 28, 2019 10:00 pm

Kmall is this odd?

Post by rccola335 » Tue Jan 17, 2023 2:24 am

"Great opportunity to join a commercial team at Geron in a leadership role that will lead and support the launch of a novel therapy for LR-MDS patients. This position will be part of the Trade & Channel Relations team."
This was posted by Peter Avalos on LinkedIn in response to a Geron posting for a job - he seems to work for Daiichi Sankyo

biopearl123
Posts: 1670
Joined: Fri Jul 20, 2018 5:13 pm

Re: Kmall is this odd?

Post by biopearl123 » Tue Jan 17, 2023 2:34 am

Used to, now he works at Geron and seems happy and proud about it. Nothing odd about that.

https://ir.geron.com/investors/press-re ... fault.aspx

kmall
Posts: 756
Joined: Thu Mar 21, 2019 3:57 pm

Re: Kmall is this odd?

Post by kmall » Tue Jan 17, 2023 3:54 am

rccola335- Bp is correct.....as of December 2022, Peter Avalos is now a Geron employee. As you know from his LinkedIn resume, he was previously employed with JNJ for 18yrs.

Upon joining Geron, he posted this as well on his LinkedIn page:

"My journey at Daiichi Sankyo has come to an end. I thoroughly enjoyed the experience, growth, and strong connections that were made over my close to 4 years of time. Those will not be forgotten.
It was an absolute pleasure working and partnering with the DSI team.
# Thank you, Chad B and Lerryn T for all your support.
# Look forward to my next growth opportunity..."
-Peter A. Avalos


On December 14, 2022, we discovered his employment with Geron:


http://imetelchat.imetelstat.eu/viewtop ... f=1&t=1444


Peter Avalos is the 22nd former JNJ or Janssen employee hired by Geron since the September 27, 2018 Discontinuation with JNJ.

Former Janssen and JNJ employees hired since 9/27/2018 now at Geron:

Janssen -
1. Dr. Aleksandra Rizo - Sr. Medical and Regulatory Advisor - 2019
2. Dr. Faye Feller, MD – CMO – 2019
3. Laurie Sherman – VP Clinical Operations – 2019
4. Souria Dougherty - Ex Director Clinical Science - 2019
5. Jennifer Riggs - Associate Director Clinical Science - 2022
6. Anil Kapur - COO - 2019
7. Oliver Gessner - Sr. Director, Business Insights and Analytics, Hematology - 2022
8. Rana F. – Director, Statistical Programming - 2020
9. Bharat Baral – CMC Manager – 2021 & 2011
10. William Garzon-Rodriguez - Associate Director Drug Product Manufacturing – 2021
11. Sharon McBain - VP Global Regulatory - 2019
12. Shirin Mirshamsi – Director EU, Regulatory – 2019
13. Ilesh Sanathra - Director Global, Regulatory – 2020
14. Ronan Balicanta - Sr Manager, Regulatory Submissions - 2022
15. Ying Wan – VP, Biostatistics - 2019
16. Libo Sun – Director, Biostatistics - 2019


JNJ
1. Nishan Sengupta - VP, Market-Access, Pricing, Evidence Strategy - 2021
2. Scott Hutson - VP Sales - 2022
3. Lorraine S - VP Marketing - 2022
4. Tarin Araujo - Sr Manager US, Regulatory - 2022
5. Joyce Reader - Sr Regulatory Consultant UK, Regulatory - 2022
6. Peter A. Avalos - VP Trade & Channel Relations - 2022

*Something tells me there will be more former JNJ/Janssen employees announced in the very near future. -Kmall

Post Reply